The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2022Development of a Safe and Efficient Method to Treat Parkinson’s Disease Using RNA-based Gene Therapy
Study Rationale: Gene mutations are one of several cause of Parkinson’s disease (PD). Developing an efficient method for introducing functional versions of these mutated genes into cells that are...
-
Therapeutic Pipeline Program, 2022Evaluating the Efficacy of a mGluR5 Modulator in Preclinical Models of Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is one of many neurodegenerative diseases that are characterized by the buildup of misfolded protein aggregates in the brain. Preclinical data suggest that...
-
Spring 2022 RFA: Target Advancement Program - Target Validation, 2022Examining the Action of Potassium Channels and the Inflammasome in a Signaling Axis That Can Serve as a Pharmacological Target Against Parkinson’s Disease
Study Rationale: Both voltage-gated potassium channels and inflammatory signaling are known to be involved in Parkinson’s disease (PD). Each of these signaling systems contributes to the brain...
-
Expanding Biological Understanding of PD, 2022Identifying Genes that Enhance the Activity of Glucocerebrosidase
Study Rationale: Parkinson’s disease (PD) causes uncontrollable trembling, progressive rigidity of muscles and an inability to walk. We do not yet understand why certain people are more prone than...
-
Research Grant, 2022Development of Irreversible PET Radiotracers for Glucocerebrosidase
Study Rationale: Glucocerebrosidase (GBA) is an enzyme that removes a sugar that is attached to certain fat molecules in the healthy brain. This critical biochemical process begins to malfunction...
-
Spring 2022 RFA: Target Advancement Program - Target Validation, 2022Production of Preclinical Model of REM Sleep Behavior Disorder Using Alpha-synuclein Fibrils
Study Rationale: REM sleep behavior disorder (RBD) is characterized by abnormal motor behaviors during the REM phase of sleep and is highly predictive of Parkinson’s disease (PD). A brain region...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.